Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
PHASE4
The primary objective of this study is to assess the efficacy of olanzapine...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
PHASE4
The main goal of this study is to help answer the following research questi...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study
N/A
The aim of this project is to investigate the multimodal magnetic resonance...
Status
Unknown
Location
The First Affiliated Hospital of Chongqing Medical University
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
PHASE4
The purpose of this study is to examine whether olanzapine, compared to ris...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Weight Gain Management in Patients With Schizophrenia
PHASE4
Evaluate the efficacy of nizatidine in reducing/limiting weight gain in pat...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician